Multinational firms showing lukewarm attitudes over direct dealing with Dongwon

Most of foreign-invested pharmaceutical firms have opened their direct transactions with Dongwon Group’s affiliated wholesalers, but some of multinational companies are still inactive, according to market observers.

Currently, three multinational companies ― Novartis Korea, Boehringer Ingelheim Korea and Sanofi-Aventis ― have belatedly joined other firms to make direct transaction with Dongw...